Europe Ophthalmology Market - Industry Trends and Forecast to 2030
Description
Europe Ophthalmology Market - Industry Trends and Forecast to 2030
The Europe ophthalmology market is projected to register a substantial CAGR of 5.8 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Europe Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Russia, Spain, Turkey, Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania, and Rest of Europe.), Industry Trends and Forecast to 2030.
Some of the major factors contributing to the growth of the Europe ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population
Market Players
Some of the key market players for the Europe Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
The Europe ophthalmology market is projected to register a substantial CAGR of 5.8 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Europe Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Russia, Spain, Turkey, Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania, and Rest of Europe.), Industry Trends and Forecast to 2030.
Some of the major factors contributing to the growth of the Europe ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population
Market Players
Some of the key market players for the Europe Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
410 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Ophthalmology Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Europe Ophthalmology Market: Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Product Segment Lifeline Curve
- 2.8 Dbmr Market Position Grid
- 2.9 Vendor Share Analysis
- 2.10 Market End User Coverage Grid
- 2.11 Secondary Sources
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 5 Epidemiology
- 6 Strategic Initiatives
- 7 Europe Ophthalmology Market, Regulation
- 8 Market Overview
- 8.1 Drivers
- 8.1.1 Rising Prevalence Of Ophthalmic Disorders & Ocular Pains
- 8.1.2 Increasing Unhygienic & Sedentary Lifestyle
- 8.1.3 Rise In Traumatic Injuries
- 8.1.4 Rise In The Geriatric Population
- 8.2 Restraints
- 8.2.1 High Cost & Risks Associated With Eye Surgery & Treatment
- 8.2.2 Lack Of Health Insurance Amongst The Population, Especially Within The Developing Countries
- 8.2.3 Side Effects Associated With Treatment Drugs
- 8.3 Opportunities
- 8.3.1 Rise In Healthcare Expenditure And Disposable Income
- 8.3.2 Strategic Initiatives By Key Market Players
- 8.3.3 Rising Awareness To Prevent The Burden Of Eye Diseases
- 8.4 Challenge
- 8.4.1 Lack Of Skilled Professionals
- 8.4.2 Stringent Rules & Regulations For Product Approval
- 9 Europe Ophthalmology Market, By Products
- 9.1 Overview
- 9.2 Device
- 9.2.1 Surgical Device
- 9.2.1.1 Cataract Surgical Devices
- 9.2.1.2 Ophthalmic Viscoelastic Devices
- 9.2.1.2.1 Phacoemulsification Devices
- 9.2.1.2.2 Cataract Surgical Lasers
- 9.2.1.2.3 Iol Injectors
- 9.2.1.3 Vitreoretinal Surgical Devices
- 9.2.1.3.1 Vitreoretinal Packs
- 9.2.1.3.2 Vitrectomy Machines
- 9.2.1.3.3 Vitrectomy Probes
- 9.2.1.3.4 Photocoagulation Lasers
- 9.2.1.3.5 Illumination Devices
- 9.2.1.4 Refractive Surgical Devices
- 9.2.1.4.1 Femtosecond Lasers
- 9.2.1.4.2 Excimer Lasers
- 9.2.1.4.3 Other Refractive Surgical Lasers
- 9.2.1.5 Glaucoma Surgical Devices
- 9.2.1.5.1 Glaucoma Drainage Devices
- 9.2.1.5.2 Glaucoma Laser Systems
- 9.2.1.5.3 Micro Invasive Glaucoma Surgery Devices
- 9.2.2 Diagnostic Device
- 9.2.2.1 Autorefractors & Keratometers
- 9.2.2.2 Tonometer
- 9.2.2.3 Phoropters
- 9.2.2.4 Retinoscopes
- 9.2.2.5 Ophthalmoscopes
- 9.2.2.6 Perimeters/Visual Field Analyzers
- 9.2.2.7 Ophthalmic Ultrasound Imaging Systems
- 9.2.2.7.1 A- Scan Imaging System
- 9.2.2.7.2 B-scan Imaging System
- 9.2.2.7.3 Pachymeters
- 9.2.2.7.4 Ultrasound Biomicroscopes
- 9.2.2.8 Lensmeters
- 9.2.2.9 Corneal Topography Systems
- 9.2.2.10 Optical Coherence Tomography Scanners
- 9.2.2.11 Fundus Cameras
- 9.2.2.12 Optical Biometry Systems
- 9.2.2.13 Specular Microscopes
- 9.2.2.14 Wavefront Aberrometers
- 9.2.2.15 Chart Projectors
- 9.2.2.16 Slit Lamps
- 9.2.3 Ophthalmic Surgical Accessories
- 9.2.3.1 Surgical Instruments & Kits
- 9.2.3.2 Ophthalmic Forceps
- 9.2.3.3 Ophthalmic Spatula
- 9.2.3.4 Ophthalmic Tips And Handles
- 9.2.3.5 Ophthalmic Cannulas
- 9.2.3.6 Ophthalmic Scissors
- 9.2.3.7 Others Surgical Accessories
- 9.2.4 Ophthalmic Microscopes
- 9.3 Drugs
- 9.3.1 Anti-inflammation Drugs
- 9.3.1.1 Non-steroidal Anti-inflammatory Drugs
- 9.3.1.2 Steroidal Anti-inflammatory Drugs
- 9.3.2 Allergic Conjunctivitis
- 9.3.3 Dry Eye Drugs
- 9.3.4 Retinal Disorder Drugs
- 9.3.5 Anti-glaucoma Drugs
- 9.3.5.1 Miotics
- 9.3.5.1.1 Pilocarpine
- 9.3.5.1.2 Eserine
- 9.3.5.2 Beta Adrenergic Antagonists
- 9.3.5.2.1 Timolal Maleate
- 9.3.5.2.2 Betaxolol
- 9.3.5.3 Prostaglandin Analogs
- 9.3.5.3.1 Latanoprost
- 9.3.5.3.2 Bimatoprost
- 9.3.5.3.3 Travoprost
- 9.3.5.3.4 Tafluprost
- 9.3.5.3.5 Latanoprostene
- 9.3.5.4 Alpha Adrenergic Agonists
- 9.3.5.4.1 Epinephrine
- 9.3.5.4.2 Depiveprine
- 9.3.5.5 Anti-vegf Drugs
- 9.3.5.5.1 Ranibizumab
- 9.3.5.5.2 Bevacizumab
- 9.3.6 Others
- 9.4 Others
- 9.4.1 Vision Care Products
- 9.4.1.1 Spectacles
- 9.4.1.2 Contact Lenses
- 9.4.1.2.1 Soft Contact Lenses
- 9.4.1.2.2 Hybrid Contact Lenses
- 9.4.1.2.3 Rigid Gas Permeable Lenses
- 9.4.2 Others
- 10 Europe Ophthalmology Market, By Diseases
- 10.1 Overview
- 10.2 Inflammatory Diseases
- 10.3 Cataract
- 10.4 Refractive Disorders
- 10.5 Glaucoma
- 10.6 Age-related Macular Degeneration
- 10.7 Others
- 11 Europe Ophthalmology Market, By Prescription Mode
- 11.1 Overview
- 11.2 Branded
- 11.3 Generic
- 12 Europe Ophthalmology Market, By Drug Type
- 12.1 Overview
- 12.2 Over The Counter
- 12.3 Prescription
- 13 Europe Ophthalmology Market, By Route Of Administration
- 13.1 Overview
- 13.2 Topical
- 13.2.1 Eye Drops
- 13.2.2 Eye Solution
- 13.2.3 Cream & Ointments
- 13.2.4 Gel
- 13.2.5 Others
- 13.3 Oral
- 13.3.1 Tablet
- 13.3.2 Capsules
- 13.3.3 Others
- 13.4 Local Ocular
- 13.4.1 Subconjunctival
- 13.4.2 Intravitreal
- 13.4.3 Retrobulbar
- 13.4.4 Intracameral
- 13.5 Injectable
- 13.5.1 Intramuscular
- 13.5.2 Intravenous
- 13.5.3 Others
- 13.6 Others
- 14 Europe Ophthalmology Market, By End User
- 14.1 Overview
- 14.2 Clinics
- 14.3 Hospitals
- 14.4 Homecare Settings
- 14.5 Others
- 15 Europe Ophthalmology Market, By Distribution Channel
- 15.1 Overview
- 15.2 Retail Sales
- 15.2.1 Retail Shops
- 15.2.2 Hospital Pharmacy
- 15.2.3 Online Pharmacy
- 15.3 Direct Tender
- 15.4 Others
- 16 Europe Ophthalmology Market, By Geography
- 16.1 Europe
- 16.1.1 Germany
- 16.1.2 U.K.
- 16.1.3 France
- 16.1.4 Hungary
- 16.1.5 Lithuania
- 16.1.6 Austria
- 16.1.7 Ireland
- 16.1.8 Norway
- 16.1.9 Poland
- 16.1.10 Italy
- 16.1.11 Spain
- 16.1.12 Russia
- 16.1.13 Turkey
- 16.1.14 Netherlands
- 16.1.15 Switzerland
- 16.1.16 Rest Of Europe
- 17 Europe Ophthalmology Market: Company Landscape
- 17.1 Company Share Analysis: Europe
- 18 Swot Analysis
- 19 Company Profile
- 19.1 Alcon
- 19.1.1 Company Snapshot
- 19.1.2 Recent Financials
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Developments
- 19.2 Regeneron Pharmaceuticals Inc.
- 19.2.1 Company Snapshot
- 19.2.2 Recent Financials
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Development
- 19.3 Johnson & Johnson Services, Inc.
- 19.3.1 Company Snapshot
- 19.3.2 Recent Financials
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Reichert, Inc.
- 19.4.1 Company Snapshot
- 19.4.2 Company Share Analysis
- 19.4.3 Product Portfolio
- 19.4.4 Recent Development
- 19.5 Novartis Ag
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Developments
- 19.6 Abbvie Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Recent Financials
- 19.6.3 Product Portfolio
- 19.6.4 Recent Development
- 19.7 Bausch & Lomb Incorporated
- 19.7.1 Company Snapshot
- 19.7.2 Revenue Analysis
- 19.7.3 Product Portfolio
- 19.7.4 Recent Developments
- 19.8 Carl Zeiss Meditec Ag
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- List Of Tables
- Table 1 Europe Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 2 Europe Device In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 3 Europe Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 4 Europe Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 5 Europe Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 6 Europe Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 7 Europe Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 8 Europe Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 9 Europe Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 10 Europe Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 11 Europe Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 12 Europe Drugs In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 13 Europe Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 14 Europe Anti Inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 15 Europe Anti Glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 16 Europe Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 17 Europe Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 18 Europe Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 19 Europe Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 20 Europe Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 21 Europe Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 22 Europe Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 23 Europe Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 24 Europe Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million))
- Table 25 Europe Ophthalmology Market, By Diseases 2021-2030 (Usd Million)
- Table 26 Europe Inflammatory Diseases In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 27 Europe Cataract In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 28 Europe Refractive Disorders In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 29 Europe Glaucoma In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 30 Europe Age-related Macular Degeneration In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 31 Europe Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 32 Europe Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 33 Europe Branded In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 34 Europe Generic In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 35 Europe Ophthalmology Market, By Drug Type 2021-2030 (Usd Million)
- Table 36 Europe Over The Counter In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 37 Europe Prescription In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 38 Europe Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 39 Europe Topical In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 40 Europe Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 41 Europe Oral In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 42 Europe Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 43 Europe Local Ocular In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 44 Europe Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 45 Europe Injectables In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 46 Europe Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 47 Europe Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 48 Europe Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 49 Europe Clinics In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 50 Europe Hospitals In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 51 Europe Home Healthcare In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 52 Europe Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 53 Europe Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 54 Europe Retail Sales In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 55 Europe Retail Sales In Ophthalmology Market, By Distribution Channel 2021-2030 (Usd Million)
- Table 56 Europe Direct Tender In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 57 Europe Others In Ophthalmology Market, By Region, 2021-2030 (Usd Million)
- Table 58 Europe Ophthalmology Market, By Country, 2021-2030 (Usd Million)
- Table 59 Europe Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 60 Europe Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 61 Europe Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 62 Europe Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 63 Europe Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 64 Europe Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 65 Europe Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 66 Europe Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 67 Europe Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 68 Europe Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 69 Europe Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 70 Europe Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 71 Europe Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 72 Europe Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 73 Europe Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 74 Europe Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 75 Europe Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 76 Europe Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 77 Europe Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 78 Europe Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 79 Europe Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 80 Europe Ophthalmology Market, By Diseases, 2021-2030 (Usd Million)
- Table 81 Europe Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 82 Europe Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
- Table 83 Europe Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 84 Europe Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 85 Europe Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 86 Europe Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 87 Europe Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 88 Europe Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 89 Europe Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 90 Europe Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 91 Germany Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 92 Germany Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 93 Germany Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 94 Germany Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 95 Germany Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 96 Germany Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 97 Germany Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 98 Germany Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 99 Germany Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 100 Germany Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 101 Germany Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 102 Germany Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 103 Germany Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 104 Germany Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 105 Germany Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 106 Germany Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 107 Germany Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 108 Germany Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 109 Germany Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 110 Germany Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 111 Germany Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 112 Germany Ophthalmology Market, By Diseases, 2021-2030 (Usd Million)
- Table 113 Germany Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 114 Germany Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
- Table 115 Germany Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 116 Germany Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 117 Germany Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 118 Germany Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 119 Germany Injectables In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 120 Germany Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 121 Germany Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 122 Germany Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 123 U.K. Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 124 U.K. Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 125 U.K. Surgical Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 126 U.K. Ophthalmic Viscoelastic Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 127 U.K. Vitreoretinal Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 128 U.K. Refractive Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 129 U.K. Glaucoma Surgical Devices In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 130 U.K. Diagnostic Device In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 131 U.K. Ophthalmic Ultrasound Imaging Systems In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 132 U.K. Ophthalmic Surgical Accessories In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 133 U.K. Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 134 U.K. Anti-inflammation Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 135 U.K. Anti-glaucoma Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 136 U.K. Miotics In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 137 U.K. Beta Adrenergic Antagonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 138 U.K. Prostaglandin Analogs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 139 U.K. Alpha Adrenergic Agonists In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 140 U.K. Anti-vegf Drugs In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 141 U.K. Others In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 142 U.K. Vision Care Products In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 143 U.K. Contact Lenses In Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- Table 144 U.K. Ophthalmology Market, By Diseases, 2021-2030 (Usd Million)
- Table 145 U.K. Ophthalmology Market, By Prescription Mode, 2021-2030 (Usd Million)
- Table 146 U.K. Ophthalmology Market, By Drug Type, 2021-2030 (Usd Million)
- Table 147 U.K. Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 148 U.K. Topical In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 149 U.K. Oral In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 150 U.K. Local Ocular In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 151 U.K. Injectable In Ophthalmology Market, By Route Of Administration, 2021-2030 (Usd Million)
- Table 152 U.K. Ophthalmology Market, By End User, 2021-2030 (Usd Million)
- Table 153 U.K. Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 154 U.K. Retail Sales In Ophthalmology Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 155 France Ophthalmology Market, By Products, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Europe Ophthalmology Market: Segmentation
- Figure 2 Europe Ophthalmology Market: Data Triangulation
- Figure 3 Europe Ophthalmology Market: Droc Analysis
- Figure 4 Europe Ophthalmology Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Ophthalmology Market: Company Research Analysis
- Figure 6 Europe Ophthalmology Market: Interview Demographics
- Figure 7 Europe Ophthalmology Market: Dbmr Position Grid
- Figure 8 Europe Ophthalmology Market: Vendor Share Analysis
- Figure 9 Europe Ophthalmology Market: End User Coverage Grid
- Figure 10 Europe Ophthalmology Market: Segmentation
- Figure 11 Rising Prevalence Of Ophthalmic Disorders& Increasing Geriatric Population Are Expected To Drive The Europe Ophthalmology Market From 2022 To 2029
- Figure 12 The Device Segment Is Expected To Have The Largest Share Of The Europe Ophthalmology Market From 2022 To 2029
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Ophthalmology Market
- Figure 14 Europe Ophthalmology Market: By Products, 2022
- Figure 15 Europe Ophthalmology Market: By Products, 2023-2030 (Usd Million)
- Figure 16 Europe Ophthalmology Market: By Products, Cagr (2023-2030)
- Figure 17 Europe Ophthalmology Market: By Products, Lifeline Curve
- Figure 18 Europe Ophthalmology Market: By Diseases, 2022
- Figure 19 Europe Ophthalmology Market: By Diseases, 2023-2030 (Usd Million)
- Figure 20 Europe Ophthalmology Market: By Diseases, Cagr (2023-2030)
- Figure 21 Europe Ophthalmology Market: By Diseases, Lifeline Curve
- Figure 22 Europe Ophthalmology Market: By Prescription Mode ,2022
- Figure 23 Europe Ophthalmology Market: By Prescription Mode, 2023-2030 (Usd Million)
- Figure 24 Europe Ophthalmology Market: By Prescription Mode, Cagr (2023-2030)
- Figure 25 Europe Ophthalmology Market: By Prescription Mode, Lifeline Curve
- Figure 26 Europe Ophthalmology Market: By Drug Type ,2022
- Figure 27 Europe Ophthalmology Market: By Drug Type, 2023-2030 (Usd Million)
- Figure 28 Europe Ophthalmology Market: By Drug Type, Cagr (2023-2030)
- Figure 29 Europe Ophthalmology Market: By Drug Type, Lifeline Curve
- Figure 30 Europe Ophthalmology Market: By Route Of Administration, 2022
- Figure 31 Europe Ophthalmology Market: By Route Of Administration, 2023-2030 (Usd Million)
- Figure 32 Europe Ophthalmology Market: By Route Of Administration, Cagr (2023-2030)
- Figure 33 Europe Ophthalmology Market : By Route Of Administration, Lifeline Curve
- Figure 34 Europe Ophthalmology Market: By End User, 2022
- Figure 35 Europe Ophthalmology Market: By End User, 2023-2030 (Usd Million)
- Figure 36 Europe Ophthalmology Market: By End User, Cagr (2023-2030)
- Figure 37 Europe Ophthalmology Market: By End User, Lifeline Curve
- Figure 38 Europe Ophthalmology Market: By Distribution Channel, 2022
- Figure 39 Europe Ophthalmology Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 40 Europe Ophthalmology Market: By Distribution Channel, Cagr (2023-2030)
- Figure 41 Europe Ophthalmology Market: By Distribution Channel, Lifeline Curve
- Figure 42 Europe Ophthalmology Market: Snapshot (2022)
- Figure 43 Europe Ophthalmology Market: By Country (2022)
- Figure 44 Europe Ophthalmology Market: By Country (2023 & 2030)
- Figure 45 Europe Ophthalmology Market: By Country (2022 & 2030)
- Figure 46 Europe Ophthalmology Market: Products (2023-2030)
- Figure 47 Europe Ophthalmology Market: Company Share 2022 (%) 312
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
